p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cellsRobert J. Ihry, Ajamete Kaykas, Kathleen A. Worringer et al.|Nature Medicine|2018Cited by 1k
Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific GenesRobert J. Ihry, Ajamete Kaykas, Max R. Salick et al.|Cell Reports|2019Cited by 81
DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug DiscoveryJingyao Li, Robert J. Ihry, Daniel Ho et al.|ACS Chemical Biology|2022Cited by 34
CSF Proteomics in Patients With Progressive Supranuclear PalsyAmy B. Wise, Lawren VandeVrede, Lea T. Grinberg et al.|Neurology|2024Cited by 15
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cellsRobert J. Ihry, Ajamete Kaykas, Kathleen A. Worringer et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 7